NCT06157346 Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude
| NCT ID | NCT06157346 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ruijin Hospital |
| Condition | Health |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-10-16 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2023-10-16 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Microbes and the human body maintain a complex relationship of interaction and influence. Different regions, altitudes, and dietary habits have different degrees of influence on the composition of children's intestinal flora. Therefore, the development and maturation process of children's intestinal flora in plateau areas was discovered, and its relationship with children's immunity, metabolism, and growth was understood. The mechanism of action of children's intestinal flora on immunity, growth and development was further analyzed by comparing it with people in low-altitude areas, to provide a scientific basis for improving children's health in plateau areas.
Eligibility Criteria
Inclusion Criteria: * Children aged 1-3 years old * Both men and women; * The child's legal guardian signed the informed consent to participate in the study. * The legal guardian of the child commits to follow the study procedures and cooperate with the entire study process Exclusion Criteria: * Probiotics or antibiotics within 1 month * Associated with clinically significant abnormalities in liver and kidney function, nervous system, respiratory system, and coagulation function as determined by the investigator * Unstable vital signs; * Have other underlying medical conditions * Individuals deemed unsuitable for this clinical trial.
Contact & Investigator
Chundi Xu
PRINCIPAL INVESTIGATOR
Ruijin Hospital
Frequently Asked Questions
Who can join the NCT06157346 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 3 Years, studying Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06157346 currently recruiting?
Yes, NCT06157346 is actively recruiting participants. Contact the research team at wxq11671@rjh.com.cn for enrollment information.
Where is the NCT06157346 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06157346 clinical trial?
NCT06157346 is sponsored by Ruijin Hospital. The principal investigator is Chundi Xu at Ruijin Hospital. The trial plans to enroll 300 participants.